抗氧化化合物的多靶点分析，包括重新利用和联合策略。
Multi-Target Profiling of Antioxidant Compounds, Including Repurposing and Combination Strategies.
作者信息
Rocca Roberta
机构信息
Department of Health Sciences, University Magna Græcia, 88100 Catanzaro, Italy.
出版信息
Antioxidants (Basel). 2025 Feb 15;14(2):220. doi: 10.3390/antiox14020220.
Abstract
Multifactorial diseases, such as cancer, neurodegenerative disorders, and stroke, present significant challenges in modern medicine due to their complex origins and the absence of definitive treatments [...].
摘要
诸如癌症、神经退行性疾病和中风等多因素疾病，因其起源复杂且缺乏确切的治疗方法，给现代医学带来了重大挑战[……]。
相似文献
1
Multi-Target Profiling of Antioxidant Compounds, Including Repurposing and Combination Strategies.
Antioxidants (Basel). 2025 Feb 15;14(2):220. doi: 10.3390/antiox14020220.
2
Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy.
Br J Cancer. 2024 Mar;130(5):703-715. doi: 10.1038/s41416-023-02502-9. Epub 2023 Nov 27.
3
Multi-Layer Picture of Neurodegenerative Diseases: Lessons from the Use of Big Data through Artificial Intelligence.
J Pers Med. 2021 Apr 7;11(4):280. doi: 10.3390/jpm11040280.
4
What are the challenges with multi-targeted drug design for complex diseases?
Expert Opin Drug Discov. 2022 Jul;17(7):673-683. doi: 10.1080/17460441.2022.2072827. Epub 2022 May 12.
5
Mitochondrial biogenesis: pharmacological approaches.
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
6
Does drug repurposing bridge the gaps in management of Parkinson's disease? Unravelling the facts and fallacies.
Ageing Res Rev. 2025 Mar;105:102693. doi: 10.1016/j.arr.2025.102693. Epub 2025 Feb 15.
7
New approaches for developing multi-targeted drug combinations for disease modification of complex brain disorders. Does epilepsy prevention become a realistic goal?
Pharmacol Ther. 2022 Jan;229:107934. doi: 10.1016/j.pharmthera.2021.107934. Epub 2021 Jun 30.
8
Revolutionising Neurological Therapeutics: Investigating Drug Repurposing Strategies.
CNS Neurol Disord Drug Targets. 2025;24(2):115-131. doi: 10.2174/0118715273329531240911075309.
9
Can Drug Repurposing Accelerate Precision Oncology?
Cancer Discov. 2022 Jul 6;12(7):1634-1641. doi: 10.1158/2159-8290.CD-21-0612.
10
Pills of Multi-Target HS Donating Molecules for Complex Diseases.
Int J Mol Sci. 2024 Jun 27;25(13):7014. doi: 10.3390/ijms25137014.
本文引用的文献
1
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging.
Arch Toxicol. 2023 Oct;97(10):2499-2574. doi: 10.1007/s00204-023-03562-9. Epub 2023 Aug 19.
2
Polypharmacology: promises and new drugs in 2022.
Pharmacol Rep. 2023 Aug;75(4):755-770. doi: 10.1007/s43440-023-00501-4. Epub 2023 Jun 6.
3
What are the challenges with multi-targeted drug design for complex diseases?
Expert Opin Drug Discov. 2022 Jul;17(7):673-683. doi: 10.1080/17460441.2022.2072827. Epub 2022 May 12.
4
Multi-Target Directed Compounds with Antioxidant and/or Anti- Inflammatory Properties as Potent Agents for Alzheimer's Disease.
Med Chem. 2021;17(10):1086-1103. doi: 10.2174/1573406416666201013161303.
5
A perspective on multi-target drug discovery and design for complex diseases.
Clin Transl Med. 2018 Jan 17;7(1):3. doi: 10.1186/s40169-017-0181-2.
6
Computer Aided Drug Design for Multi-Target Drug Design: SAR /QSAR, Molecular Docking and Pharmacophore Methods.
Curr Drug Targets. 2017;18(5):556-575. doi: 10.2174/1389450117666160101120822.
Zotero 插件